Involvement of MAP kinases in the control of cPLA2 and arachidonic acid release in endothelial cells

Atherosclerosis

Volumn 156, Issue 1, 2001, Pages 81-90

  Gudmundsdóttir, Ingibjörg J ^a   Halldórsson, Haraldur ^a,b   Magnúsdóttir, Kristín ^a   Thorgeirsson, Gudmundur ^a,b  

^a UNIVERSITY OF ICELAND   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

AA release; CPLA2; Endothelium; MAP kinases

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 6 OXOPROSTAGLANDIN F1 ALPHA; ARACHIDONIC ACID; CALCIMYCIN; GENISTEIN; HISTAMINE; MIDOSTAURIN; MITOGEN ACTIVATED PROTEIN KINASE; PERTUSSIS TOXIN; PERVANADATE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE A2; PROSTACYCLIN; PROTEIN KINASE C; STAUROSPORINE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; THROMBIN; TYROSINE;

ARTICLE; CONTROLLED STUDY; CYTOSOL; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME RELEASE; FATTY ACID SYNTHESIS; FATTY ACID TRANSPORT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ARACHIDONIC ACID; CYTOSOL; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; EPOPROSTENOL; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOLIPASES A; SIGNAL TRANSDUCTION; UMBILICAL VEINS;

EID: 0342936429     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00631-6     Document Type: Article

References (32)

1. Daniels I., Lindsay M.A., Keany C.I.C., Burden R.P., Fletcher J., Haynes A.P. Role of arachidonic acid and its metabolites in the priming of NADPH oxidase in human polymorphonuclear leukocytes by peritoneal dialysis effluent. Clin. Diagn. Lab. Immunol. 5:1998;683-689.
2. Huang S., Konieczkowski M., Schelling J.R., Sedor J.R. Interleukin-1 stimulates Jun N-terminal/stress-activated protein kinase by an arachidonate-dependent mechanism in mesangial cells. Kidney Int. 55:1999;1740-1749.
3. 2 superfamily of signal transduction enzymes. Trends Biochem. Sci. 22:1997;1-2.
4. 2). FEBS Lett. 410:1997;49-53.
5. 2 in allergic response and parturition. Nature. 390:1997;617-622.
6. 2. Nature. 390:1997;622-625.
7. 2 in agonist-stimulated human platelets and HeLa cells. J. Biol. Chem. 273:1998;4449-4458.
8. 2 is phosphorylated and activated by MAP kinase. Cell. 72:1993;269-278.
9. 2) by thrombin and thrombin receptor agonist peptide in human platelets. J. Biol. Chem. 270:1995;14816-14823.
10. 2 is phosphorylated in collagen and thrombin stimulated human platelets independent of protein kinase C and mitogen-activated protein kinase. J. Biol. Chem. 270:1995;25885-25892.
11. 2. J. Biol. Chem. 269:1994;19480-19487.
12. 2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets. Eur. J. Biochem. 245:1997;751-759.
13. 2) in thrombin-stimulated platelets. J. Biol. Chem. 271:1996;27723-27729.
14. Börsch-Haubold A.G., Kramer R.M., Watson S.P. Inhibition of mitogen-activated protein kinase kinase does not impair primary activation of human platelets. Biochem. J. 318:1996;207-212.
15. McNicol A., Philpott C.L., Shibou T.S., Israels S.J. Effects of the mitogen-activated protein (MAP) kinase inhibitor 2-(2′-amino-2′-methoxyphenyl)-oxanaphtalen-4-one (PD98059) on human platelet activation. Biochem. Pharm. 55:1998;1759-1767.
16. 2 by basic fibroblast growth factor via a p42 mitogen-activated protein kinase-dependent phosphorylation pathway in endothelial cells. J. Biol. Chem. 270:1995;2360-2366.
17. Wong JT, Tran K, Pierce GN, Chan AC, OK, Choy PC. Lysophosphatidylcholine stimulated the release of arachidonic acid in human endothelial cells, J Biol Chem 1998; 273:6830-6836.
18. Rousseau S., Houle F., Landry J., Huot J. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene. 15:1997;2169-2177.
19. Cohen P. The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol. 7:1997;353-361.
20. Pumiglia K.M., Lau L.F., Huang C.K., Burroughs S., Feinstein M.B. Activation of signal transduction in platelets by the tyrosine phosphatase inhibitor pervanadate (vanadyl hydroperoxide). Biochem. J. 286:1992;441-449.
21. Halldórsson H., Kjeld M., Thorgeirsson G. Role of phosphoinositides in the regulation of endothelial prostacyclin production. Arteriosclerosis. 8:1988;147-154.
22. 2 is coupled to hormonally regulated release of arachidonic acid. Proc. Natl. Acad. Sci. 89:1992;6147-6251.
23. Helgadóttir A., Halldórsson H., Magnúsdóttir K., Kjeld M., Thorgeirsson G. A role for tyrosine phosphorylation in generation of inositol phosphates and prostacyclin production in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 17:1997;287-294.
24. 2 in norepinephrine induced arachidonic acid release in rabbit aortic smooth muscle cells. J. Biol. Chem. 271:1996;30149-30157.
25. Ozaki Y., Yatomi Y., Jinnai Y., Kume S. Effects of genistein, a tyrosine kinase inhibitor, on platelet functions. Biochem. Pharm. 46:1993;395-403.
26. Börsch-Haubold A.G., Pasquet S., Watson P. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB203580 and PD98059. J. Biol. Chem. 273:1998;28766-28772.
27. 2 release but has no effect on von Willebrand factor secretion or E-selectin expression. FEBS Lett. 388:1996;180-184.
28. Patel V., Brown C., Goodwin A., Wilkie N., Boarder M.R. Phosphorylation and activation of p42 and p44 mitogen-activated protein kinase are required for the P2 purinoceptor stimulation of endothelial prostacyclin production. Biochem. J. 320:1996;221-226.
29. q-mediated mitogen-activated protein kinase activation. J. Biol. Chem. 270:1995;17148-17153.
30. q-mediated pathways on calcium/calmodulin, Pyk2, and S kinase. J. Biol. Chem. 272:1997;19125-19132.
31. Sexl V., Mancusi G., Höller C., Gloria-Maercker E., Schuetz W., Freissmuth M. Stimulation of the mitogen-activated protein kinase via the A2A-adenosine receptor in primary human endothelial cells. J. Biol. Chem. 272:1997;5792-5799.
32. 4 induced formation of inositol phosphate and prostacyclin in human umbilical vein endothelial cells. J. Cell Physiol. 177:1998;103-108.